Roivant Sciences

Roivant Sciences

Edit info

  • Founded: 2014
  • Location: New York, NY
  • Employee range: 200 - 500
  • Clinical stage: COM
  • Therapy area: Psoriasis
  • Drug types: NEU, END, GEN, ONC, DRM, IMM, INF, RAR, HEM, OPH, MUS, GI
  • Lead product: Vtama
  • Funding: $200M stock Feb 2023; $200M Nov 2018


roivant.com

linkedin.com

job board


Business:

Alliances, Collabs, Partnerships

Drug notes:

Also Clin3 atopic dermatitis; pipeline: https://www.roivant.com/pipeline

About:

Roivant Sciences is focusing on the discovery, development and commercialization of transformative medicines. To accelerate the commercialization of medicines, Roivant builds nimble subsidiaries they call “Vants” to develop novel technologies. Since inception, Roivant’s Vants have conducted 10 positive Phase 3 clinical trials and launched VTAMA®, a topical cream for the treatment of plaque psoriasis in adults. However, Roivant is advancing a broad and differentiated pipeline of investigational drugs across numerous therapeutic areas including immunology, oncology, hematology and dermatology.

Roivant Sciences
Associate, Governance
Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|56 days ago
Roivant Sciences
Principal, Roivant Health
Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|84 days ago
Roivant Sciences
Associate, Roivant Health
Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|84 days ago
Roivant Sciences
Director of Pharmacovigilance Systems and Operatio...
Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|93 days ago
Roivant Sciences
Vice President of Clinical Operations (Remote)
Roivant Sciences, Inc., 151 West 42nd Street, 15th Floor, New York, NY 10036, United States|100+ days ago


© 2025 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com